Savara (SVRA) Enterprise Value (2010 - 2026)
Savara (SVRA) reported Enterprise Value of -$202.8 million for Q1 2026, down 17.52% year-over-year from -$245.9 million in Q1 2025, and up 13.97% on a QoQ basis from -$235.7 million in Q4 2025.
Savara (SVRA) has 17 years of Enterprise Value data on file, last reported at -$202.8 million in Q1 2026.
- Quarterly Enterprise Value fell 17.52% year-over-year to -$202.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$202.8 million (down 17.52% YoY) and the FY2025 annual result came in at -$235.7 million, down 20.06% from the prior year.
- Enterprise Value improved to -$202.8 million in Q1 2026 per SVRA's latest filing, from -$235.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$105.1 million in Q2 2023 and bottomed at -$235.7 million in Q4 2025.
- The 5-year median for Enterprise Value is -$146.4 million (2025), against an average of -$156.9 million.
- The widest annual swing landed in 2024, when Enterprise Value slumped 30.39%; it then surged 43.32% in 2025.
- Tracing SVRA's Enterprise Value over 5 years: stood at -$125.9 million in 2022, then decreased by 28.95% to -$162.3 million in 2023, then declined by 20.95% to -$196.3 million in 2024, then decreased by 20.06% to -$235.7 million in 2025, then advanced by 13.97% to -$202.8 million in 2026.
- Per Business Quant, the three latest SVRA Enterprise Value figures stand at -$202.8 million (Q1 2026), -$235.7 million (Q4 2025), and -$124.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | -202.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.78 Mn |
| Dec 31, 2025 | -235.70 Mn |
| Sep 30, 2025 | -124.39 Mn |
| Jun 30, 2025 | -146.40 Mn |
| Mar 31, 2025 | -172.54 Mn |
| Dec 31, 2024 | -196.33 Mn |
| Sep 30, 2024 | -219.44 Mn |
| Jun 30, 2024 | -121.60 Mn |
| Mar 31, 2024 | -143.10 Mn |
| Dec 31, 2023 | -162.32 Mn |
| Sep 30, 2023 | -168.29 Mn |
| Jun 30, 2023 | -105.10 Mn |
| Mar 31, 2023 | -114.78 Mn |
| Dec 31, 2022 | -125.88 Mn |
| Sep 30, 2022 | -134.04 Mn |
| Jun 30, 2022 | -142.45 Mn |
| Mar 31, 2022 | -151.80 Mn |
| Dec 31, 2021 | -161.17 Mn |
| Sep 30, 2021 | -170.80 Mn |
| Jun 30, 2021 | -180.70 Mn |
| Mar 31, 2021 | -192.73 Mn |
| Dec 31, 2020 | -82.19 Mn |
| Sep 30, 2020 | -94.30 Mn |
| Jun 30, 2020 | -99.62 Mn |
| Mar 31, 2020 | -104.99 Mn |
| Dec 31, 2019 | -121.76 Mn |
| Sep 30, 2019 | -106.28 Mn |
| Jun 30, 2019 | -111.73 Mn |
| Mar 31, 2019 | -105.18 Mn |
| Dec 31, 2018 | -110.83 Mn |
| Sep 30, 2018 | -112.05 Mn |
| Jun 30, 2018 | -74.76 Mn |
| Mar 31, 2018 | -84.98 Mn |
| Dec 31, 2017 | -94.31 Mn |
| Sep 30, 2017 | -53.29 Mn |
| Jun 30, 2017 | -61.13 Mn |
| Mar 31, 2017 | -10.46 Mn |
| Dec 31, 2016 | -13.37 Mn |
| Sep 30, 2016 | -15.51 Mn |
| Jun 30, 2016 | -14.06 Mn |
| Mar 31, 2016 | -23.52 Mn |
| Dec 31, 2015 | -16.68 Mn |
| Sep 30, 2015 | -32.21 Mn |
| Jun 30, 2015 | -21.21 Mn |
| Mar 31, 2015 | -27.93 Mn |
| Dec 31, 2014 | -12.69 Mn |
| Sep 30, 2014 | -25.98 Mn |
| Jun 30, 2014 | -26.37 Mn |
| Mar 31, 2014 | -29.85 Mn |
| Dec 31, 2013 | -25.68 Mn |
| Sep 30, 2013 | -30.23 Mn |
| Jun 30, 2013 | -53.42 Mn |
| Mar 31, 2013 | -32.01 Mn |
| Dec 31, 2012 | -36.51 Mn |
| Sep 30, 2012 | -39.90 Mn |
| Jun 30, 2012 | -43.07 Mn |
| Mar 31, 2012 | -46.05 Mn |
| Dec 31, 2011 | -50.70 Mn |
| Sep 30, 2011 | -38.29 Mn |
| Jun 30, 2011 | -41.96 Mn |
| Mar 31, 2011 | -46.55 Mn |
| Dec 31, 2010 | -27.98 Mn |
| Sep 30, 2010 | -29.33 Mn |
| Jun 30, 2010 | -31.16 Mn |